| Ident. | Authors (with country if any) | Title |
|---|
| 000012 (2020) |
F. Yang [République populaire de Chine] ; N. Liu ; J Y Hu ; L L Wu ; G S Su ; N S Zhong ; Z G Zheng | [Pulmonary rehabilitation guidelines in the principle of 4S for patients infected with 2019 novel coronavirus (2019-nCoV)]. |
| 000014 (2020) |
H. Li [République populaire de Chine] ; Y M Wang [République populaire de Chine] ; J Y Xu [République populaire de Chine] ; B. Cao [République populaire de Chine] | [Potential antiviral therapeutics for 2019 Novel Coronavirus]. |
| 000029 (2020) |
Y. Si [République populaire de Chine] ; X F Sun [République populaire de Chine] ; M. Zhong [République populaire de Chine] ; J N Yue [République populaire de Chine] ; W G Fu [République populaire de Chine] | [Countermeasures and treatment for aortic acute syndrome with 2019 coronavirus disease]. |
| 000041 (2020) |
J. Wang [République populaire de Chine] ; B J Wang [République populaire de Chine] ; J C Yang [République populaire de Chine] ; M Y Wang [République populaire de Chine] ; C. Chen [République populaire de Chine] ; G X Luo [République populaire de Chine] ; W F He [République populaire de Chine] | [Advances in the research of mechanism of pulmonary fibrosis induced by Corona Virus Disease 2019 and the corresponding therapeutic measures]. |
| 000067 (2020) |
Haiou Li [République populaire de Chine] ; Yunjiao Zhou [République populaire de Chine] ; Meng Zhang [République populaire de Chine] ; Haizhou Wang [République populaire de Chine] ; Qiu Zhao [République populaire de Chine] ; Jing Liu [République populaire de Chine] | Updated approaches against SARS-CoV-2. |
| 000069 (2020) |
Joseph Thomas Ortega [États-Unis] ; Maria Luisa Serrano [Venezuela] ; Flor Helene Pujol [Venezuela] ; Hector Rafael Rangel [Venezuela] | Unrevealing sequence and structural features of novel coronavirus using in silico approaches: The main protease as molecular target |
| 000092 (2020) |
Robert L. Kruse [États-Unis] | Therapeutic strategies in an outbreak scenario to treat the novel coronavirus originating in Wuhan, China. |
| 000102 (2020) |
Weilong Shang ; Yi Yang ; Yifan Rao ; Xiancai Rao | The outbreak of SARS-CoV-2 pneumonia calls for viral vaccines |
| 000105 (2020) |
Raquel Martins Lana [Brésil] ; Flávio Codeço Coelho [Brésil] ; Marcelo Ferreira Da Costa Gomes [Brésil] ; Oswaldo Gonçalves Cruz [Brésil] ; Leonardo Soares Bastos [Brésil] ; Daniel Antunes Maciel Villela [Brésil] ; Cláudia Torres Codeço [Brésil] | The novel coronavirus (SARS-CoV-2) emergency and the role of timely and effective national health surveillance. |
| 000106 (2020) |
Dana Rose Garfin ; Roxane Cohen Silver ; E Alison Holman | The novel coronavirus (COVID-2019) outbreak: Amplification of public health consequences by media exposure. |
| 000115 (2020) |
Jin-Yan Li [République populaire de Chine] ; Zhi You [République populaire de Chine] ; Qiong Wang [République populaire de Chine] ; Zhi-Jian Zhou [République populaire de Chine] ; Ye Qiu [République populaire de Chine] ; Rui Luo [République populaire de Chine] ; Xing-Yi Ge [République populaire de Chine] | The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future. |
| 000141 (2020) |
Dandan Wu [République populaire de Chine] ; Xuexian O. Yang [États-Unis] | TH17 responses in cytokine storm of COVID-19: An emerging target of JAK2 inhibitor Fedratinib. |
| 000187 (2020) |
Hao Yu ; Xu Sun ; Wei Deng Solvang ; Xu Zhao | Reverse Logistics Network Design for Effective Management of Medical Waste in Epidemic Outbreaks: Insights from the Coronavirus Disease 2019 (COVID-19) Outbreak in Wuhan (China) |
| 000232 (2020) |
Yu Wai Chen [Hong Kong] ; Chin-Pang Bennu Yiu [Hong Kong] ; Kwok-Yin Wong [Hong Kong] | Prediction of the SARS-CoV-2 (2019-nCoV) 3C-like protease (3CL
pro) structure: virtual screening reveals velpatasvir, ledipasvir, and other drug repurposing candidates |
| 000255 (2020) |
G. Kampf [Allemagne] ; D. Todt [Allemagne] ; S. Pfaender [Allemagne] ; E. Steinmann [Allemagne] | Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents. |
| 000278 (2020) |
Yadi Zhou [États-Unis] ; Yuan Hou [États-Unis] ; Jiayu Shen [États-Unis] ; Yin Huang [États-Unis] ; William Martin [États-Unis] ; Feixiong Cheng [États-Unis] | Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2 |
| 000310 (2020) |
Xingchen Pan [République populaire de Chine] ; David M. Ojcius [États-Unis] ; Tianyue Gao [Canada] ; Zhongsheng Li [République populaire de Chine] ; Chunhua Pan [République populaire de Chine] ; Chungen Pan [République populaire de Chine] | Lessons learned from the 2019-nCoV epidemic on prevention of future infectious diseases. |
| 000331 (2020) |
Muh-Yong Yen [Taïwan] ; Jonathan Schwartz [États-Unis] ; Shey-Ying Chen [Taïwan] ; Chwan-Chuen King [Taïwan] ; Guang-Yang Yang [Taïwan] ; Po-Ren Hsueh [Taïwan] | Interrupting COVID-19 transmission by implementing enhanced traffic control bundling: Implications for global prevention and control efforts. |
| 000354 (2020) |
Jia Liu [République populaire de Chine] ; Ruiyuan Cao [République populaire de Chine] ; Mingyue Xu [République populaire de Chine] ; Xi Wang [République populaire de Chine] ; Huanyu Zhang [République populaire de Chine] ; Hengrui Hu [République populaire de Chine] ; Yufeng Li [République populaire de Chine] ; Zhihong Hu [République populaire de Chine] ; Wu Zhong [République populaire de Chine] ; Manli Wang [République populaire de Chine] | Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro |
| 000374 (2020) |
Chih-Cheng Lai [Taïwan] ; Cheng-Yi Wang [Taïwan] ; Ya-Hui Wang [Taïwan] ; Shun-Chung Hsueh [Taïwan] ; Wen-Chien Ko [Taïwan] ; Po-Ren Hsueh [Taïwan] | Global epidemiology of coronavirus disease 2019: disease incidence, daily cumulative index, mortality, and their association with country healthcare resources and economic status. |
| 000399 (2020) |
Yixiang Ng ; Zongbin Li ; Yi Xian Chua ; Wei Liang Chaw ; Zheng Zhao ; Benjamin Er ; Rachael Pung ; Calvin J. Chiew ; David C. Lye ; Derrick Heng ; Vernon J. Lee | Evaluation of the Effectiveness of Surveillance and Containment Measures for the First 100 Patients with COVID-19 in Singapore - January 2-February 29, 2020. |
| 000404 (2020) |
Jianhui Nie [République populaire de Chine] ; Qianqian Li [République populaire de Chine] ; Jiajing Wu [République populaire de Chine] ; Chenyan Zhao [République populaire de Chine] ; Huan Hao [République populaire de Chine] ; Huan Liu [République populaire de Chine] ; Li Zhang [République populaire de Chine] ; Lingling Nie [République populaire de Chine] ; Haiyang Qin [République populaire de Chine] ; Meng Wang [République populaire de Chine] ; Qiong Lu [République populaire de Chine] ; Xiaoyu Li [République populaire de Chine] ; Qiyu Sun [République populaire de Chine] ; Junkai Liu [République populaire de Chine] ; Changfa Fan [République populaire de Chine] ; Weijin Huang [République populaire de Chine] ; Miao Xu [République populaire de Chine] ; Youchun Wang [République populaire de Chine] | Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-2. |
| 000483 (2020) |
Lindsey R. Baden ; Eric J. Rubin | Covid-19 - The Search for Effective Therapy. |
| 000529 (2020) |
Zhenwei Wang [République populaire de Chine] ; Xiaorong Chen [République populaire de Chine] ; Yunfei Lu [République populaire de Chine] ; Feifei Chen [République populaire de Chine] ; Wei Zhang [République populaire de Chine] | Clinical characteristics and therapeutic procedure for four cases with 2019 novel coronavirus pneumonia receiving combined Chinese and Western medicine treatment. |
| 000540 (2020) |
Wanbo Tai [États-Unis] ; Lei He [République populaire de Chine] ; Xiujuan Zhang [États-Unis] ; Jing Pu [États-Unis, République populaire de Chine] ; Denis Voronin [États-Unis] ; Shibo Jiang [États-Unis, République populaire de Chine] ; Yusen Zhou [République populaire de Chine] ; Lanying Du [États-Unis] | Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine |
| 000573 (2020) |
Dan Zhou [République populaire de Chine] ; Sheng-Ming Dai [République populaire de Chine] ; Qiang Tong [République populaire de Chine] | COVID-19: a recommendation to examine the effect of hydroxychloroquine in preventing infection and progression. |
| 000620 (2020) |
Magdalena Wujtewicz [Pologne] ; Anna Dylczyk-Sommer [Pologne] ; Aleksander Aszkiełowicz [Pologne] ; Szymon Zdanowski [Pologne] ; Sebastian Piwowarczyk [Pologne] ; Radoslaw Owczuk [Pologne] | COVID-19 - what should anaethesiologists and intensivists know about it? |
| 000633 (2020) |
Chih-Cheng Lai [Taïwan] ; Yen Hung Liu [Taïwan] ; Cheng-Yi Wang [Taïwan] ; Ya-Hui Wang [Taïwan] ; Shun-Chung Hsueh [Taïwan] ; Muh-Yen Yen [Taïwan] ; Wen-Chien Ko [Taïwan] ; Po-Ren Hsueh [Taïwan] | Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Facts and myths. |
| 000660 (2020) |
Andrea Cortegiani [Italie] ; Giulia Ingoglia [Italie] ; Mariachiara Ippolito [Italie] ; Antonino Giarratano [Italie] ; Sharon Einav [Israël] | A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19. |
| 000670 (2020) |
Bin Cao ; Yeming Wang ; Danning Wen ; Wen Liu ; Jingli Wang ; Guohui Fan ; Lianguo Ruan ; Bin Song ; Yanping Cai ; Ming Wei ; Xingwang Li ; Jiaan Xia ; Nanshan Chen ; Jie Xiang ; Ting Yu ; Tao Bai ; Xuelei Xie ; Li Zhang ; Caihong Li ; Ye Yuan ; Hua Chen ; Huadong Li ; Hanping Huang ; Shengjing Tu ; Fengyun Gong ; Ying Liu ; Yuan Wei ; Chongya Dong ; Fei Zhou ; Xiaoying Gu ; Jiuyang Xu ; Zhibo Liu ; Yi Zhang ; Hui Li ; Lianhan Shang ; Ke Wang ; Kunxia Li ; Xia Zhou ; Xuan Dong ; Zhaohui Qu ; Sixia Lu ; Xujuan Hu ; Shunan Ruan ; Shanshan Luo ; Jing Wu ; Lu Peng ; Fang Cheng ; Lihong Pan ; Jun Zou ; Chunmin Jia ; Juan Wang ; Xia Liu ; Shuzhen Wang ; Xudong Wu ; Qin Ge ; Jing He ; Haiyan Zhan ; Fang Qiu ; Li Guo ; Chaolin Huang ; Thomas Jaki ; Frederick G. Hayden ; Peter W. Horby ; Dingyu Zhang ; Chen Wang | A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19. |
| 000671 (2020) |
Alba Grifoni [États-Unis] ; John Sidney [États-Unis] ; Yun Zhang [États-Unis] ; Richard H. Scheuermann [États-Unis] ; Bjoern Peters [États-Unis] ; Alessandro Sette [États-Unis] | A Sequence Homology and Bioinformatic Approach Can Predict Candidate Targets for Immune Responses to SARS-CoV-2. |
| 000699 (2018) |
Lan Li ; Xuwen Qiao ; Jin Chen ; Yuanpeng Zhang ; Qisheng Zheng ; Jibo Hou | Surface-displayed porcine reproductive and respiratory syndrome virus from cell culture onto gram-positive enhancer matrix particles |
| 000718 (2017) |
Ali A. Rabaan ; Shamsah H. Alahmed ; Ali M. Bazzi ; Hatem M. Alhani | A review of candidate therapies for Middle East respiratory syndrome from a molecular perspective |
| 000737 (2015) |
Rajinder Sandhu ; Sandeep K. Sood ; Gurpreet Kaur | An intelligent system for predicting and preventing MERS-CoV infection outbreak |
| 000741 (2014) |
Mahendra Rai ; Kateryna Kon [Ukraine] ; Avinash Ingle ; Nelson Duran ; Stefania Galdiero [Italie] ; Massimiliano Galdiero [Italie] | Broad-spectrum bioactivities of silver nanoparticles: the emerging trends and future prospects |
| 000742 (2014) |
Petr Jansa [République tchèque] ; Antonín Hol [République tchèque] ; Martin Dra Nsk [République tchèque] ; Viktor Kolman [République tchèque] ; Zlatko Janeba [République tchèque] ; Petra Kostecká [République tchèque] ; Eva Kmoní Ková [République tchèque] ; Zden K Zídek [République tchèque] | 5-Substituted 2-amino-4,6-dihydroxypyrimidines and 2-amino-4,6-dichloropyrimidines: synthesis and inhibitory effects on immune-activated nitric oxide production |
| 000746 (2013) |
Suphla Gupta [Inde] ; Pankaj Pandotra [Inde] ; Ajai P. Gupta [Inde] ; M. K. Verma [Inde] ; Ashok Ahuja [Inde] ; Ram A. Vishwakarma [Inde] | Direct rhizogenesis, in vitro stolon proliferation and high-throughput regeneration of plantlets in Glycyrrhiza glabra |
| 000747 (2013) |
Amit K. Halder [Inde] ; Achintya Saha [Inde] ; Tarun Jha [Inde] | Exploration of structural and physicochemical requirements and search of virtual hits for aminopeptidase N inhibitors |
| 000752 (2012) |
Pradeep Kumar [Inde] ; Balasubramanian Narasimhan [Inde] ; Kalavathy Ramasamy [Malaisie] ; Vasudevan Mani [Malaisie] ; Rakesh Kumar Mishra [Malaisie] ; Abu Bakar Abdul Majeed [Malaisie] ; Erik De Clercq [Belgique] | N ′-[4-[(Substituted imino)methyl]benzylidene]-substituted benzohydrazides: synthesis, antimicrobial, antiviral, and anticancer evaluation, and QSAR studies |
| 000756 (2011) |
Sanjay Batra [États-Unis] ; Gayathriy Balamayooran [États-Unis] ; Malaya K. Sahoo [États-Unis] | Nuclear Factor-κB: a Key Regulator in Health and Disease of Lungs |
| 000800 (2005) |
T B Ferreira [Portugal] ; P M Alves [Portugal] ; J G Aunins [États-Unis] ; M J T. Carrondo [Portugal] | Use of adenoviral vectors as veterinary vaccines |
| 000810 (1996) |
Michael C. F. Tong [Hong Kong] ; Ming Chi Chu [Hong Kong] ; Susanna E. J. Leighton [Hong Kong] ; C. Andrew Van Hasselt [Hong Kong] | Adult Croup |
| 000830 (????) |
Daniel Antunes Maciel Villela [Brésil] | The value of mitigating epidemic peaks of COVID-19 for more effective public health responses |
| 000833 (????) |
Aaron M. Wendelboe [États-Unis] ; Amanda Miller [États-Unis] ; Douglas Drevets [États-Unis] ; Linda Salinas [États-Unis] ; E J Miller [États-Unis] ; Dalton Jackson [États-Unis] ; Ann Chou [États-Unis] ; Jill Raines [États-Unis] | Tabletop exercise to prepare institutions of higher education for an outbreak of COVID-19. |
